Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.
about
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneNucleotide Excision Repair and Vitamin D--Relevance for Skin Cancer TherapyThe association between Vitamin D and health outcomes in women: A review on the related evidenceThe roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.Vitamin D suppresses leptin stimulation of cancer growth through microRNA.Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.Synergy of 1,25-dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV-3 cells.CYP24A1 inhibition enhances the antitumor activity of calcitriol.Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.Evidence of differential effects of vitamin d receptor variants on epithelial ovarian cancer risk by predicted vitamin d status.Serum vitamin D, vitamin D binding protein, and lung cancer survivalThe coupling of epidermal growth factor receptor down regulation by 1alpha,25-dihydroxyvitamin D3 to the hormone-induced cell cycle arrest at the G1-S checkpoint in ovarian cancer cells.Effects of 1α,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cellsVitamin D and cardiovascular disease and cancer: not too much and not too little? The need for clinical trialsCataract and ovarian carcinoma: is the vitamin D hypothesis alive?Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor1α,25(OH)2 Vitamin D3 Modulates Avian T Lymphocyte Functions without Inducing CTL Unresponsiveness.1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498.Vitamin D and cancer: clinical aspects.Potent 19-norvitamin D analogs for prostate and liver cancer therapyInecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model systemAssociation Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies1α,25(OH)₂D₃ Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal TransitionCirculating vitamin d and risk of epithelial ovarian cancer.Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue.Surrogates of long-term vitamin d exposure and ovarian cancer risk in two prospective cohort studiesAntiproliferative Effects of 1α-OH-vitD3 in Malignant Melanoma: Potential Therapeutic implications.19-Norvitamin D analogs for breast cancer therapy.New insights into vitamin D anticancer properties: focus on miRNA modulation.Highly sensitive detection of telomerase based on a DNAzyme strategy.Clinical and Metabolic Response to Vitamin D Supplementation in Endometrial Hyperplasia: a Randomized, Double-Blind, Placebo-Controlled Trial.1, 25-dihydroxyvitamin D3 decreases adriamycin-induced podocyte apoptosis and loss.High Prevalence of Vitamin D Deficiency in Newly Diagnosed Acute Myeloid Leukemia Patients and Its Adverse Outcome.22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma.Use of dairy products, lactose, and calcium and risk of ovarian cancer - results from a Danish case-control study.Relative expression of 1,25-dihydroxyvitamin D3 receptor, vitamin D 1 alpha-hydroxylase, vitamin D 24-hydroxylase, and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers.RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression.
P2860
Q26739925-DB0D119A-64CB-4EF8-9F83-BAC89FB02A01Q26750627-1F8FA10C-B029-4BBE-A814-EB80F4B2E0ACQ28078810-A7CB7DBA-0EFF-4A49-8967-6855D3B33099Q30235880-167AD78B-DA38-425C-8328-7B2C1E697DA9Q30367127-544F7723-2736-492E-8385-86989D346ED4Q33802601-DD124F9F-4DCD-4310-989D-7E54E4E6A19EQ33942599-AEC33C82-408B-4444-A8BA-7B5943CB7468Q33967557-D22F2FE6-3A93-4436-9AA8-1BBF61FF7C2AQ34132307-0585B7F1-A6CB-49C6-8633-210D6481ED10Q34274328-75CF6DEC-D552-4B38-BD90-A90CFF58D12EQ34368796-3E959665-3C5E-40A2-872D-6070CFCF1F1CQ34713803-B70552BA-AD6F-4DD9-B923-B4A28091B40DQ34949693-82255B0A-AABF-4C4C-9568-17A59149F0F1Q35038553-6E923699-03ED-4841-A3DB-E94580135633Q35229958-CB2826C4-EE11-4A77-8070-80CB34629758Q35613177-8CC55314-43D8-4AFF-8D30-8CFC2E3550A7Q35646945-A2CE9A0B-FDFE-496E-9414-A1ED664F141AQ35737779-3A3ADABA-BB44-44AC-B4F9-A9889DC57600Q35933893-7F7A05BC-1CF5-486F-A5A0-95F250FBF3CEQ36436094-EB61185B-DF38-404F-8603-7429332BD4DEQ36509508-D2B790C2-3578-4894-840F-8A41625A9135Q36682230-96C6CE27-0BEF-4CFD-B6A2-0DD62BC2CAACQ36724263-480E3994-2CD9-4FB9-B031-FAA6418F25EEQ36786297-16529E75-C428-42FE-8E94-058202A1D00AQ37153564-D035A949-9682-4018-9E46-1814FEF4AF8AQ37210064-465CA33B-EE21-4A48-B728-94B3DB74B735Q37326053-4D64BB30-EC2C-4E72-A1E6-3666C3EE0EF4Q37357558-078B0443-B480-46CB-933A-348D875E1A99Q37420609-8132CAC0-038E-4C33-82B7-9397F5721F6DQ37578871-139DFE20-1ACB-4FD6-BF4C-2A03007E26CEQ38445909-D92BC62C-489C-4C5C-8059-9C2240D680A7Q38938169-000423CC-D699-458B-B6E1-61B8550DBC26Q39189683-B12190C7-5343-4AB7-99A6-DDEB193A3165Q40297111-B06D70F2-9A93-4783-BDA9-0379772EDE14Q41897679-80C853D6-BD0E-4158-B83F-317F7BF32C52Q42285092-3838A0DE-163D-414E-9054-1FF60C955402Q42948495-3E6A16F3-DB2F-4060-B92E-CAF4CE413909Q43728176-70290179-9BAA-4A5A-B21E-F5420DAD0453Q46968715-1D5861CB-BCCC-42D3-8833-03CDDE3E49C3Q48846069-D587C297-3CA5-465E-A0C0-D2D609C5C276
P2860
Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Induction of ovarian cancer ce ...... down-regulation of telomerase.
@en
type
label
Induction of ovarian cancer ce ...... down-regulation of telomerase.
@en
prefLabel
Induction of ovarian cancer ce ...... down-regulation of telomerase.
@en
P2093
P2860
P356
P1476
Induction of ovarian cancer ce ...... down-regulation of telomerase.
@en
P2093
Feng Jiang
Junying Bao
Pengfei Li
Santo V Nicosia
Wenlong Bai
P2860
P304
53213-53221
P356
10.1074/JBC.M410395200
P407
P577
2004-10-12T00:00:00Z